How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/pet-scan-with-11c-abp688.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

PET Scan with [11C]ABP688 — Competitive Intelligence Brief

PET Scan with [11C]ABP688 (PET Scan with [11C]ABP688) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: PET imaging agent / Radiotracer. Area: Neurology / Psychiatry / Diagnostic Imaging.

marketed PET imaging agent / Radiotracer mGluR5 (metabotropic glutamate receptor 5) Neurology / Psychiatry / Diagnostic Imaging Small molecule Live · refreshed every 30 min

Target snapshot

PET Scan with [11C]ABP688 (PET Scan with [11C]ABP688) — Stony Brook University. [11C]ABP688 is a positron emission tomography (PET) tracer that binds to metabotropic glutamate receptor 5 (mGluR5) to enable imaging of mGluR5 expression in the brain.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
PET Scan with [11C]ABP688 TARGET	PET Scan with [11C]ABP688	Stony Brook University	marketed	PET imaging agent / Radiotracer	mGluR5 (metabotropic glutamate receptor 5)
C-11 labeled nicotine	C-11 labeled nicotine	University of Cincinnati	marketed	PET imaging agent / radiotracer	Nicotinic acetylcholine receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (PET imaging agent / Radiotracer class)

Alessandro D'Agnolo · 1 drug in this class
Stony Brook University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). PET Scan with [11C]ABP688 — Competitive Intelligence Brief. https://druglandscape.com/ci/pet-scan-with-11c-abp688. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab